Licensing and Technology Transfer for Life Science and Tech Companies: ENET Meeting, Feb. 21, 2017

In two weeks, on Tuesday, February 21, 2017 at 6pm, the Boston Entrepreneurs’ Network (ENET), will hold a meeting with speakers on this subject, at the group’s new location in Cambridge, at Pivotal Labs, at 145 Broadway, 3rd Floor, just outside of Kendall Square, across the street from Akamai Technologies and just two doors down from Biogen.

Are you an inventor or entrepreneur seeking to license technology from a university or a research establishment?

Are you a technology owner seeking to license it out to existing companies to gain revenue? Or to develop, commercialize and market your products and create a new start-up company?

Our speakers will offer both perspectives discussing licensing technology from Institutions and research establishments. What are typical and atypical terms? What and how to negotiate? At what stage of development can we attract seed investment? How do we assess the commercialization and marketability? What unmet needs are met and how bad is the “pain”, i.e. market size or a unique strategy? How to transition from the lab into viable and profitable products, i.e. “mind-to market” strategy? Typical terms and payment structures the entrepreneur or the Angel/Angel group, VC will seek in licensing will be discussed. What is royalty, fees and dividends? What are the license fees and milestones? What is the equity for the licensor? What are terms on sublicensing and royalty stacking?

Our speakers will also discuss licensing technology to a newly formed start-ups and early stage companies. They will also discuss licensing terms and offer insights – dos and don’ts – for entrepreneurs and start-up companies to successfully license technology from Institutions.

In addition, our speakers will also speak as a licensor, discussing how their institution/research establishment licenses out technology. Others discussions items will involve terms that a small or mid-size high tech company seek, as it licenses out its technology to generate revenue, as it acquires technology through cross-licensing, as it secures sources of supply, as it maximizes incentives to gain sales and market traction, and the implications of licensing on mergers and acquisitions.

Whether you are or want to be a technology licensor or licensee, there is much to learn from the experience of our speakers.

Agenda:

6:00 – 7:00 PM Registration & networking

7:00 – 7:10 PM ENET Chairman’s announcements

7:10 -7:25 PM E Minute – Up to 3 Startup companies’ presentations

7:25 -8:15 PM – 3 expert speakers on the night’s topic

8:15 -8:30 PM – Audience / Speakers Q & A

8:30 -9:00 PM – Final networking including meeting speakers

Venue: Pivotal Labs, 145 Broadway, 3rd Floor, Cambridge, MA

Parking:  After 6:00 pm, the parking fee for Blue Garage next door is $10

Panel:

brian-waingerBrian J. Wainger, MD, PhD. Dr. Wainger is Assistant Professor in Anesthesiology and Neurology at Harvard Medical School and an attending physician at Massachusetts General Hospital. He studied molecular biology as an undergraduate at Princeton University and ion channel physiology in the MD/PhD program at Columbia University. He then completed medical residency in the Partners Neurology Program followed by a clinical fellowship in Pain Medicine at MGH, research fellowship with Clifford Woolf at Boston Children’s Hospital and clinical investigator training through the Harvard Master’s Program in Clinical and Translational Investigation. His clinical expertise spans the intersection of neurology and pain medicine.

lori-pressmanLori Pressman. Lori Pressman has been an independent deal maker, license negotiator, business development and technology transfer strategic advisor since 2000. Recent assignments include licensing biotech and oncology inventions for academic medical centers, and securing IP licenses for small companies in energy and instrumentation.   She was a Director at Harris & Harris (NASDAQ:TINY) from 2002-2012, an advisor for Axsun Technologies prior to its acquisition by Volcano, and Assistant Director with signatory authority of the MIT Technology Licensing Office.

She is a member of the grant review committee at the MIT Deshpande Center for Technological Innovation and frequent coach of entrepreneurs and students studying entrepreneurship and business development.  She is a reasonable royalty damages expert, a metrics guru for AUTM and BIO, and a member of the AUTM Public Policy Committee. She is an inventor on a half dozen medical device patents and earned the SB, Physics from MIT and the MSEE from the Columbia School of Engineering. Earlier in her career, she was a practicing engineer, working on optoelectronic materials and devices at Bell Laboratories and Lasertron, an MIT Lincoln Laboratory start-up.

abi-barrowAbi Barrow. Director, Office of Technology Commercialization and Ventures, UMASS  abarrow@umassp.eduDr. Abigail Barrow is the Interim Executive Director, Office of Technology Commercialization and Ventures (OTCV) at the University of Massachusetts.  She joined the UMass President’s Office in 2004 as the Founding Director of the Massachusetts Technology Transfer Center (MTTC) which is housed in OTCV. At OTCV she supports the campus technology transfer programs as well as assisting with start-up formation and other system wide entrepreneurship activities at UMass. She is also responsible for the overall management of the MTTC and the development of its programs. Prior to joining UMass, Dr. Barrow served as managing director of William J. von Liebig Center at the University of California San Diego (UCSD). The von Liebig Center was created in 2001 to support the commercialization of research being performed in the UCSD Jacobs School of Engineering.

Dr. Barrow worked in a variety of roles at UCSD CONNECT from 1990 to 2001. At CONNECT, she developed and expanded many of its programs to support early-stage company formation and technology commercialization. The CONNECT program is internationally recognized and has been successfully replicated in many other regions around the world.

Dr. Barrow is on the board and is Chair of Venture Well (formerly the National Collegiate Inventors and Innovators Alliance). Dr. Barrow received her Ph.D. from the Science Studies Unit and a B.Sc. in Mechanical Engineering from the University of Edinburgh.

Moderator and Organizer: 

nathalie_goletianiDr. Nathalie Goletiani, MD, Founder & CEO, POWERFEM Therapeutics. Dr. Goletiani is the Founder and Chief Executive Officer of POWERFEM Therapeutics, a company devoted to novel, networked treatment methods for the care of those suffering from substance abuse and mental illness. Her extensive clinical research into the hormonal effects of nicotine, opioid and cocaine use lead her to new concepts and mechanisms in understanding and treating psychiatric disorders, in particular, disorders experienced by underserved female populations. At Harvard’s McLean Hospital, she was charged with rebuilding and responsible for all the operations of Clinical Research Program, including simultaneously running multiple clinical trials. Based on her patented work, she founded POWERFEM Therapeutics, an independent company devoted to creating new treatments and healthcare solutions. POWERFEM incorporates novel disease concepts and treatments to design cost-effective, integrated mental and substance abuse care solutions across multiple provider networks.

Dr. Goletiani has received numerous national and international awards including most recently the Harvard Livingston Award for the investigation of complex underlying mechanisms in the neurobiology of women. She also received a Harvard University Zinberg Fellowship specifically to support her research on alcohol and drug use disorders. Her research provides a valuable basis for psychotherapeutic public policy decision making on issues of substance abuse and the integrated treatment of mental illness. She has extensively published the results of her research in peer reviewed journals.

Nathalie completed basic and clinic fellowships at the Harvard School of Public Health and at Harvard Medical School. In addition, she has been trained at and conducted medical research at Tbilisi State Medical University, University of Amsterdam and King’s College in London.

For more information or to register for the February 21 ENET meeting in Cambridge, go to LINK:  http://boston-enet.org/event-2314309 or   www.boston-enet.org

Hopefully, this meeting on Licensing and Technology Transfer will be helpful to the tech and life science entrepreneurs in small and early stage companies I represent.  Hope to see you at Pivotal Labs in Cambridge in two weeks, 6pm on February 21!

For additional ENET information on Licensing Technology for Startups…

I helped the meeting organizer for this meeting.

speakers

Several years earlier, I also organized and moderated another ENET panel on Licensing Technology for Startup Companies, in February 2010, in Waltham.  To see speakers backgrounds that night, go to http://boston-enet.org/event-114832

That night we explored these questions:

  • Are you an inventor or entrepreneur seeking to license technology from a university?
  • Are you a company owner seeking to license out your technology to gain revenue? or to market your products?

Our panel will approach the topic “Licensing Technology” from both sides.

Leslie Williams, our first speaker offered both perspectives discussing licensing technology from hospitals and universities. At what stage of development can we attract seed investment? How do we assess marketability? What unmet needs are met? How to transition from the lab into products? She will discuss what terms and payment structures will the entrepreneur or the VC seek in licensing. What royalty? What license fees and milestones? What equity for the licensor? What terms on sublicensing and royalty stacking?

Jack Turner, our second speaker discussed licensing MIT technology to early stage companies. He too will discuss university licensing terms and offer insights – dos and don’ts – for entrepreneurs and startup companies to successfully license technology from MIT.

Mark Morley, our third speaker spoke as a licensor, discussing how his company licenses out technology. He will discuss terms that a small or mid-size high tech company seeks as it licenses out its technology to generate revenue, as it acquires technology through cross-licensing, as it secures sources of supply, as it maximizes incentives to gain sales and market traction, and the implications of licensing on mergers and acquisitions.

You can access slides from talks by Jack Turner and Leslie Williams at http://boston-enet.org/event-114832

Hopefully, these presentations on technology licensing from my earlier panel, as well as the presentations on February 21 in Cambridge, will be helpful to entrepreneurs in small and early stage companies I represent.

My Continuing role as ENET Chairman and frequent speaker & moderator…

I remain active in ENET, a Waltham and Cambridge based non-profit group, affiliated with IEEE, that aids tech and life science founders, entrepreneurs, small and early stage companies, and people who invest or work in those companies.  www.boston-enet.org

A member of the ENET Board since 2002, I have served as Chairman of this non-profit group since 2009.  In May 2015, I was elected to my fourth 2-year term as ENET Chair.  During the period of my leadership, ENET’s annual program has grown from 10 meetings per year to 19 for 2015-16 year just completed:  10 meetings in Waltham, and 9 in Kendall Square Cambridge, plus our annual cruise of Boston Harbor to end the program year.  Each meeting has three or more speakers on a subject of interest to entrepreneurs and company founders, in life science, tech and other areas of New England’s innovation economy.  Each meeting also has ample networking time before and after the presentations to allow entrepreneurs to meet each other and later meet with the speakers

image002On January 30, 2016, at a ceremony at the national meeting of IEEE-USA in Las Vegas, NV, the President of that organization Peter Eckstein (pictured below) presented me with the IEEE-USA professional achievement award for “extreme dedication and contributions to the IEEE entrepreneurial community”.  For more information on that award, see LINK:  http://www.boston-enet.org/IEEE-USA-Professional-Achievement-Award

In the prior program year, Sept 2015 to July 2016, I organized and moderated five of 19 ENET’s meetings, that included moderating and speaking at these meetings.

On May 17, 2016, I was organizer, moderator and a speaker on ” Impact Entrepreneurship and Your Triple Bottom Line”, with Cheryl Kiser, Mark Donohue and Rebecca Hamilton, an all-star panel on this subject, where I concluded the proceedings speaking about certified B corps and Chapter 156E the newly enacted benefit corporation law in Massachusetts.  to see my slides and others, go to http://www.boston-enet.org/event-2017624

On April 5, 2016, I was meeting organizer and moderator for the ENET meeting on “Strategic Alliances for M&A and Successful Exits”.  We had three great speakers including Charles Lax on Grand Banks Capital and Richard Kimball of Bigelow & Associates.  To see my write up on the meeting and slides from each of our four speakers, go to http://www.boston-enet.org/event-2017600

On January 5, 2016, I was meeting organizer and moderator for the ENET meeting on Product Development in Life Science & Tech Startups.”   We had four wonderful and quite complimentary speakers, a full house in Waltham, with 112 in attendance, and great audience questions.  We began with the big picture of product development across life science fields and then focused on a single company’s successful development, launching and sales of a customer-driven medical device / consumer product.  Then moving to tech, our third speaker focused on key design issues and our 4th speaker closed on scaling and production issues.  To see my write up on the meeting and slides from each of our four speakers, go to http://www.boston-enet.org/event-2017595

On October 6, 2015, I was meeting organizer and moderator for the ENET meeting on “Innovative Ways to Bootstrap Your Startup Company.”   We had three great speakers, a full house in Waltham and great audience questions.  To see my write up on the meeting and slides from each of our three ENET speakers, go to http://boston-enet.org/event-2017582

joanneOne of the highlights of the October 6 ENET meeting was the presentation of  Joanne Lang, Founder and CEO of AboutOne, www.aboutone.com/about/our-story/   Joanne is based in Philadelphia and flew in special, at her own cost, to give her presentation for ENET.  Joanne’s slides, “”Bring Your Product to Market Bootstrapped Style… and Keep it there” –  were also excellent, a great and continuing resource for founders and entrepreneurs to use and reference, LINK  http://boston-enet.org/resources/Documents/Presentation_Lang.pdf

 

 

 

 

Advertisements